Ligand validation:6MIA

1CE: 3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

1CE is a Ligand Of Interest in 6MIA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MIA_1CE_A_303	85%	13%	0.094	0.959	2.12	1.84	3	3	0	0	100%	0.79
6MIA_1CE_A_301	65%	17%	0.124	0.924	2.06	1.53	2	2	0	0	100%	0.7
6MIA_1CE_B_302	49%	15%	0.149	0.897	2.19	1.64	4	2	1	0	100%	0.78
6MIA_1CE_A_302	37%	15%	0.178	0.877	2.17	1.64	4	3	0	0	100%	0.67
6MIA_1CE_B_301	9%	13%	0.266	0.759	2.26	1.7	5	3	0	0	100%	0.72
6MIA_1CE_B_303	0%	13%	0.53	0.395	2.28	1.72	4	3	0	0	100%	0.63
3G34_1CE_B_4	48%	5%	0.138	0.881	2.74	2.63	10	9	0	0	100%	0.5
6MNP_1CE_A_302	39%	17%	0.188	0.893	2.33	1.28	4	1	1	0	100%	0.91

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.